Induced Pluripotent Stem Cells Derived from Alzheimer’s Disease Patients: The Promise, the Hope and the Path Ahead
The future hope of generated induced pluripotent stem cells (iPS cells) from Alzheimer’s disease patients is multifold. Firstly, they may help to uncover novel mechanisms of the disease, which could lead to the development of new and unprecedented drugs for patients and secondly, they could also be...
Main Authors: | Kristine Freude, Carlota Pires, Poul Hyttel, Vanessa Jane Hall |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/3/4/1402 |
Similar Items
-
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
by: Dmitry A. Ovchinnikov, et al.
Published: (2014-12-01) -
Important advances in Alzheimer’s disease from the use of induced pluripotent stem cells
by: Fernanda Majolo, et al.
Published: (2019-02-01) -
Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
by: Wei Wuli, et al.
Published: (2020-02-01) -
Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
by: Anna Ochalek, et al.
Published: (2017-12-01) -
Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer’s Disease
by: Juan Antonio Garcia-Leon, et al.
Published: (2020-09-01)